Outbrain Full Year 2024 Earnings: Misses Expectations

Outbrain (NASDAQ:OB) Full Year 2024 Results

Key Financial Results

• Revenue: US$889.9m (down 4.9% from FY 2023).
• Net loss: US$711.0k (down by 107% from US$10.2m profit in FY 2023).
• US$0.014 loss per share (down from US$0.20 profit in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Outbrain Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) was also behind analyst expectations.

The primary driver behind last 12 months revenue was the Europe, The Middle East and Africa (EMEA) segment contributing a total revenue of US$541.4m (61% of total revenue). Notably, cost of sales worth US$697.8m amounted to 78% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to US$97.5m (51% of total expenses). Explore how OB's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Interactive Media and Services industry in the US.

Performance of the American Interactive Media and Services industry.

The company's shares are down 12% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Outbrain that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.